A First in Human Study in Healthy Volunteers and in Participants With Frontotemporal Dementia With Granulin (GRN) Mutation

Clinical trial NCT03636204 · COMPLETED

Trial details

NCT number: NCT03636204
Sponsor: Alector Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Frontotemporal Dementia

Start date: 2018-09-14
Primary completion: 2019-12-31
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.